Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 88Leukemia 58Lymphoma 42Burkitt Lymphoma 36Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, Large B-Cell, Diffuse 19Lymphoma, Follicular 17Lymphoma, Non-Hodgkin 16Lymphoma, Mantle-Cell 15Lymphoma, B-Cell, Marginal Zone 15Lymphoma, Large-Cell, Immunoblastic 11Leukemia, Biphenotypic, Acute 10Multiple Myeloma 9Lymphoma, Large-Cell, Anaplastic 9Hodgkin Disease 9Blast Crisis 9Myelodysplastic Syndromes 8Recurrence 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6Leukemia, Myeloid, Accelerated Phase 6Hematologic Neoplasms 6Waldenstrom Macroglobulinemia 5Primary Myelofibrosis 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Acute 5

Interventions

Imatinib Mesylate 14Dasatinib 5nilotinib 4bosutinib 4Cyclophosphamide 4fludarabine 3Vincristine 3Methotrexate 3Dexamethasone 3Cytarabine 3peginterferon alfa-2a 2fludarabine phosphate 2asciminib 2Prednisone 2Daunorubicin 2Azacitidine 2Acetaminophen 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2venetoclax 1thymoglobulin 1ponatinib 1olverembatinib 1flumatinib 1blinatumomab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Rituximab 1Prednisolone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Philadelphia Chromosome × Prednisone × Other hematologic neoplasm × Clear all
NCT02523976 2026-02-11

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06220487 2024-01-24

ABC

Nanfang Hospital, Southern Medical University

Phase 2 Recruiting
67 enrolled
LymphoidOther hematologic neoplasm

Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡